Arca Biopharma sell StockNews.com
Start price
17.07.24
/
50%
€3.18
Target price
17.07.25
-
Performance (%)
57.47%
End price
18.07.25
-
Summary
This prediction is currently being closed. The price for Arca Biopharma has massively increased, which is bad news for the SELL prediction by StockNews_com. Dividends of €2.85 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arca Biopharma | - | - | - |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten